drugset / Trial / NCT01987739
Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users
RandomizedCrossoverTriple-blind
Summary
This was a six-way crossover study with six single-dose treatment sessions. The profile of acute effects on abuse potential measures of different almorexant doses was compared to that of placebo and two doses of zolpidem
Timeline
- Start
- 2009-09
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zolpidem | Small molecule | 20 mg | Oral |
| Subject | Zolpidem | Small molecule | 40 mg | Oral |
| Subject | almorexant | Small molecule | 200 mg | Oral |
| Subject | almorexant | Small molecule | 400 mg | Oral |
| Subject | almorexant | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.